Another 46 participants using fructooligosaccharide supplementation (12 g/day) or a placebo over 3 months showed a notable decrease in IL-6 and a nonsignificant trend toward lowering pCS.
← all excerpts
Gut-derived uremic toxins and cardiovascular health in chronic kidney disease.
1
—
—